Structure Therapeutics Inc. 8-K

What Happened

• Structure Therapeutics Inc. announced on February 26, 2026 that it issued a press release providing a corporate update and reporting its financial results for the fourth quarter ended December 31, 2025. The press release is furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: February 26, 2026.
• Reporting period: fourth quarter ended December 31, 2025.
• Press release included as Exhibit 99.1; an Inline XBRL cover page (Exhibit 104) was also furnished.
• The company states the information in this Form 8-K (including Exhibit 99.1) is furnished—not “filed”—for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings except as expressly stated.

Why It Matters

• This 8-K signals that Structure Therapeutics has publicly released its quarterly earnings and a corporate update; investors should review the press release for specific earnings figures (revenue, net loss/profit, cash position) and any guidance or operational updates.
• The furnished Inline XBRL makes the reported financial data machine-readable for analysts and tools.
• The Section 18 disclosure means the press release is provided for informational purposes with limited legal liabilities and is not automatically incorporated into other SEC filings.